Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The left ventricular dysfunction questionnaire (LVD-36): reliability, validity, and responsiveness.

C J O'Leary1, P W Jones

  • 1Division of Physiological Medicine, St George's Hospital Medical School, Cranmer Terrace, London SW17 0RE, UK.

Heart (British Cardiac Society)
|May 18, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Salbutamol use in relation to maintenance bronchodilator efficacy in COPD: a prospective subgroup analysis of the EMAX trial.

Respiratory research·2020
Same author

Simple non-mydriatic retinal photography is feasible and demonstrates retinal microvascular dilation in Chronic Obstructive Pulmonary Disease (COPD).

PloS one·2020
Same author

Chronic kidney disease, worsening renal function and outcomes in a heart failure community setting: A UK national study.

International journal of cardiology·2018
Same author

Consumer segmentation and time interval between types of hospital admission: a clinical linkage database study.

Journal of public health (Oxford, England)·2017
Same author

Serum testosterone, testosterone replacement therapy and all-cause mortality in men with type 2 diabetes: retrospective consideration of the impact of PDE5 inhibitors and statins.

International journal of clinical practice·2016
Same author

Non-cardiovascular comorbidity, severity and prognosis in non-selected heart failure populations: A systematic review and meta-analysis.

International journal of cardiology·2015
Same journal

Feasibility of early double sequential defibrillation in out-of-hospital cardiac arrest: the double-D randomised pilot trial.

Heart (British Cardiac Society)·2026
Same journal

Correspondence on 'When a patent foramen ovale becomes pathological' by Saji and Ohara.

Heart (British Cardiac Society)·2026
Same journal

Cost-effectiveness of N-terminal pro-B-type natriuretic peptide thresholds for echocardiography referral in primary care heart failure management.

Heart (British Cardiac Society)·2026
Same journal

Optimal timing of aspirin discontinuation after acute coronary syndrome treated with percutaneous coronary intervention: a systematic review and meta-analysis.

Heart (British Cardiac Society)·2026
Same journal

Importance of rating: the impact of establishing age and sex normative values for left ventricular strain rate.

Heart (British Cardiac Society)·2026
Same journal

Man in his 40s with palpitations.

Heart (British Cardiac Society)·2026
See all related articles

The new LVD-36 tool reliably measures health status in patients with left ventricular dysfunction. This short, valid instrument is easy to use and accurately reflects changes in patient health.

Area of Science:

  • Cardiology
  • Health Outcomes Research
  • Medical Device Evaluation

Background:

  • Left ventricular dysfunction significantly impacts patient health status.
  • Existing health status measures may lack optimal content validity, clarity, brevity, or ease of use for this population.
  • A need exists for a well-validated, patient-centered health status measure for left ventricular dysfunction.

Purpose of the Study:

  • To evaluate the reliability, validity, and responsiveness of the LVD-36, a novel health status measure.
  • To confirm the LVD-36's suitability for patients with left ventricular dysfunction, emphasizing its design principles.
  • To compare the LVD-36's performance against established measures.

Main Methods:

  • A cohort of 60 patients with chronic left ventricular dysfunction was recruited from a London hospital.

Related Experiment Videos

  • The LVD-36 was administered at baseline, one week, and six months.
  • Concurrent measures included the SF-36, LIhFE, NYHA criteria, exercise tests, and echocardiography.

    • Main Results:

    • The LVD-36 demonstrated excellent internal consistency (kappa = 0.95) and repeatability (r = 0.95).
    • LVD-36 scores correlated significantly with general health (SF-36), exercise capacity, and systolic function (p < 0.0001).
    • The measure effectively captured changes in health status over six months, performing comparably or better than the LIhFE.

    Conclusions:

    • The LVD-36 is a reliable and valid health status measure for patients with left ventricular dysfunction.
    • Its brevity, simplicity, and ease of use make it a practical tool for clinical assessment.
    • The LVD-36 shows promise in accurately assessing health status and treatment response in this patient group.